{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:06:24Z","timestamp":1784041584762,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"the Beijing Bethune Charitable Foundation","award":["dxkyj003"],"award-info":[{"award-number":["dxkyj003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pain Ther"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s40122-026-00847-6","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:41:55Z","timestamp":1778859715000},"page":"1131-1145","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative Cost-Utility and Clinical Efficacy of 5-HT3 Receptor Antagonists in Sufentanil-Based PCIA: A Propensity Score-Matched Analysis"],"prefix":"10.1007","volume":"15","author":[{"given":"Youmei","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3331-1019","authenticated-orcid":false,"given":"Fangfang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"issue":"4","key":"847_CR1","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s40122-024-00619-0","volume":"13","author":"L Huang","year":"2024","unstructured":"Huang L, Zhang T, Wang K, Chang B, Fu D, Chen X. Postoperative multimodal analgesia strategy for enhanced recovery after surgery in elderly colorectal cancer patients. Pain Ther. 2024;13(4):745\u201366.","journal-title":"Pain Ther"},{"key":"847_CR2","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.2147\/JPR.S363743","volume":"15","author":"Z Nie","year":"2022","unstructured":"Nie Z, Cui X, Zhang R, et al. Effectiveness of Patient-Controlled Intravenous Analgesia (PCIA) with sufentanil background infusion for post-cesarean analgesia: a randomized controlled trial. J Pain Res. 2022;15:1355\u201364.","journal-title":"J Pain Res"},{"issue":"5","key":"847_CR3","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s40122-025-00762-2","volume":"14","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Wang JJ, Ping ZG, et al. The impact of opioid-sparing analgesia on postoperative pain and recovery: a systematic review and meta-analysis of randomized controlled trials. Pain Ther. 2025;14(5):1473\u201397.","journal-title":"Pain Ther"},{"issue":"4","key":"847_CR4","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.bpa.2020.05.003","volume":"34","author":"P Kranke","year":"2020","unstructured":"Kranke P, Meybohm P, Diemunsch P, Eberhart LHJ. Risk-adapted strategy or universal multimodal approach for PONV prophylaxis? Best Pract Res Clin Anaesthesiol. 2020;34(4):721\u201334.","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"50","key":"847_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013698","volume":"97","author":"P Chen","year":"2018","unstructured":"Chen P, Chen F, Zhou BH. Compatibility and stability of dezocine and tropisetron in 0.9% sodium chloride injection for patient-controlled analgesia administration. Medicine (Baltimore). 2018;97(50):e13698.","journal-title":"Medicine (Baltimore)"},{"issue":"Suppl 1","key":"847_CR6","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/S0959-8049(05)80255-2","volume":"29A","author":"F Roila","year":"1993","unstructured":"Roila F, Tonato M, Basurto C, et al. Ondansetron. Eur J Cancer. 1993;29A(Suppl 1):S16-21.","journal-title":"Eur J Cancer"},{"issue":"10","key":"847_CR7","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.2165\/00003495-200464100-00006","volume":"64","author":"MA Siddiqui","year":"2004","unstructured":"Siddiqui MA, Scott LJ. Palonosetron. Drugs. 2004;64(10):1125\u201332 (discussion 33-4).","journal-title":"Drugs"},{"issue":"1","key":"847_CR8","first-page":"33","volume":"27","author":"L Nijland","year":"2019","unstructured":"Nijland L, Schmidt P, Frosch M, et al. Subcutaneous or intravenous opioid administration by patient-controlled analgesia in cancer pain: a systematic literature review. Support Care Cancer. 2019;27(1):33\u201342.","journal-title":"Support Care Cancer"},{"issue":"2","key":"847_CR9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2165\/00003088-199529020-00004","volume":"29","author":"F Roila","year":"1995","unstructured":"Roila F, Del Favero A. Ondansetron clinical pharmacokinetics. Clin Pharmacokinet. 1995;29(2):95\u2013109.","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"847_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1586\/era.09.175","volume":"10","author":"C Ruhlmann","year":"2010","unstructured":"Ruhlmann C, Herrstedt J. Palonosetron hydrochloride for the prevention of chemotherapy-induced nausea and vomiting. Expert Rev Anticancer Ther. 2010;10(2):137\u201348.","journal-title":"Expert Rev Anticancer Ther"},{"key":"847_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2022-011535","author":"Z Zhu","year":"2023","unstructured":"Zhu Z, Wang Q, Sun Q, Lexchin J, Yang L. Improving access to medicines and beyond: the national volume-based procurement policy in China. BMJ Glob Health. 2023. https:\/\/doi.org\/10.1136\/bmjgh-2022-011535.","journal-title":"BMJ Glob Health"},{"issue":"3","key":"847_CR12","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/bja\/aer505","volume":"108","author":"PS Myles","year":"2012","unstructured":"Myles PS, Wengritzky R. Simplified postoperative nausea and vomiting impact scale for audit and post-discharge review. Br J Anaesth. 2012;108(3):423\u20139.","journal-title":"Br J Anaesth"},{"issue":"1","key":"847_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s40122-021-00339-9","volume":"11","author":"L Xin","year":"2022","unstructured":"Xin L, Hou N, Zhang Z, Feng Y. The effect of preoperative ultrasound-guided erector spinae plane block on chronic postsurgical pain after breast cancer surgery: a propensity score-matched cohort study. Pain Ther. 2022;11(1):93\u2013106.","journal-title":"Pain Ther"},{"issue":"3","key":"847_CR14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41372-022-01487-2","volume":"43","author":"G Peltz","year":"2023","unstructured":"Peltz G, Jansson LM, Adeniyi-Jones S, et al. Ondansetron to reduce neonatal opioid withdrawal severity a randomized clinical trial. J Perinatol. 2023;43(3):271\u20136.","journal-title":"J Perinatol"},{"issue":"9","key":"847_CR15","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1200\/JCO-24-01308","volume":"43","author":"H Zhou","year":"2025","unstructured":"Zhou H, Zhao Y, Zhang M, et al. Randomized, phase III trial of mixed formulation of fosrolapitant and palonosetron (HR20013) in preventing cisplatin-based highly emetogenic chemotherapy-induced nausea and vomiting: PROFIT. J Clin Oncol. 2025;43(9):1123\u201336.","journal-title":"J Clin Oncol"},{"issue":"3","key":"847_CR16","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/EJA.0000000000000932","volume":"36","author":"EL Carvalho Braga","year":"2019","unstructured":"Carvalho Braga EL, Figueiredo NV, Barrucand L, Cavalcanti IL. Use of palonosetron and ondansetron in the prophylaxis of postoperative nausea and vomiting in women 60 years of age or older undergoing laparoscopic cholecystectomy: a randomised double-blind study. Eur J Anaesthesiol. 2019;36(3):241\u20132.","journal-title":"Eur J Anaesthesiol"},{"issue":"2","key":"847_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.clinthera.2013.12.013","volume":"36","author":"SS Dychter","year":"2014","unstructured":"Dychter SS, Harrigan R, Bahn JD, et al. Tolerability and pharmacokinetic properties of ondansetron administered subcutaneously with recombinant human hyaluronidase in minipigs and healthy volunteers. Clin Ther. 2014;36(2):211\u201324.","journal-title":"Clin Ther"},{"issue":"1","key":"847_CR18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1213\/ANE.0000000000000002","volume":"118","author":"TJ Gan","year":"2014","unstructured":"Gan TJ, Diemunsch P, Habib AS, et al. Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2014;118(1):85\u2013113.","journal-title":"Anesth Analg"},{"key":"847_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.660514","volume":"9","author":"T Qiu","year":"2021","unstructured":"Qiu T, Men P, Sun T, Zhai S. Cost-effectiveness of Aprepitant in preventing chemotherapy-induced nausea and vomiting: a systematic review of published articles. Front Public Health. 2021;9:660514.","journal-title":"Front Public Health"},{"issue":"1","key":"847_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12961-024-01250-3","volume":"22","author":"Y Yang","year":"2024","unstructured":"Yang Y, Zhang J, Duan Y, et al. Increased consumption of cardiovascular drugs under volume-based procurement (VBP) policy: demand release or assessment inducing? Health Res Policy Syst. 2024;22(1):157.","journal-title":"Health Res Policy Syst"},{"issue":"3","key":"847_CR21","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1097\/00000542-199909000-00022","volume":"91","author":"CC Apfel","year":"1999","unstructured":"Apfel CC, Laara E, Koivuranta M, Greim CA, Roewer N. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology. 1999;91(3):693\u2013700.","journal-title":"Anesthesiology"},{"issue":"15-16","key":"847_CR22","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.drudis.2007.06.011","volume":"12","author":"MS Benedetti","year":"2007","unstructured":"Benedetti MS, Whomsley R, Canning M. Drug metabolism in the paediatric population and in the elderly. Drug Discov Today. 2007;12(15\u201316):599\u2013610.","journal-title":"Drug Discov Today"},{"issue":"7986","key":"847_CR23","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41586-023-06680-7","volume":"623","author":"JW Lovelace","year":"2023","unstructured":"Lovelace JW, Ma J, Yadav S, et al. Vagal sensory neurons mediate the Bezold-Jarisch reflex and induce syncope. Nature. 2023;623(7986):387\u201396.","journal-title":"Nature"},{"issue":"4","key":"847_CR24","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/j.1476-5381.1995.tb13283.x","volume":"114","author":"RM Eglen","year":"1995","unstructured":"Eglen RM, Lee CH, Smith WL, et al. Pharmacological characterization of RS 25259-197, a novel and selective 5-HT3 receptor antagonist, in vivo. Br J Pharmacol. 1995;114(4):860\u20136.","journal-title":"Br J Pharmacol"}],"container-title":["Pain and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-026-00847-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40122-026-00847-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-026-00847-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T14:36:14Z","timestamp":1784039774000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40122-026-00847-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["847"],"URL":"https:\/\/doi.org\/10.1007\/s40122-026-00847-6","relation":{},"ISSN":["2193-8237","2193-651X"],"issn-type":[{"value":"2193-8237","type":"print"},{"value":"2193-651X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"assertion":[{"value":"21 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Youmei Wu, Yingchao Ye, Han Gong, and Fangfang Xia have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was approved by the Ethics Committee of The First Affiliated Hospital of Wenzhou Medical University (approval no. KY2025-R216, Date: July 11, 2025). The requirement for informed consent was waived due to the retrospective nature of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}